Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Apr;80(1-2):70–72. doi: 10.1038/sj.bjc.6690323

Allele loss and mutation screen at the Peutz-Jeghers (LKB1) locus (19p13.3) in sporadic ovarian tumours

Z-J Wang 1,2, M Churchman 1, I G Campbell 3, W-H Xu 2, Z-Y Yan 2, W G McCluggage 4, W D Foulkes 5, I P M Tomlinson 1,6
PMCID: PMC2363028  PMID: 10389980

Abstract

Germline mutations in the LKB1 (STK11) gene (chromosome sub-band 19p13.3) cause characteristic hamartomas and pigmentation to develop in patients with Peutz-Jeghers syndrome. Peutz-Jeghers syndrome carries an overall risk of cancer that may be up to 20 times that of the general population and Peutz-Jeghers patients are at increased risk of benign and malignant ovarian tumours, particularly granulosa cell tumours. Loss of heterozygosity (allele loss, LOH) has been reported in about 50% of ovarian cancers on 19p13.3. LKB1 is therefore a candidate tumour suppressor gene for sporadic ovarian tumours. We found allele loss at the marker D19S886 (19p13.3) in 12 of 49 (24%) sporadic ovarian adenocarcinomas. Using SSCP analysis, we screened ten ovarian cancers with LOH, 35 other ovarian cancers and 12 granulosa cell tumours of the ovary for somatic mutations in LKB1. No variants were detected in any of the adenocarcinomas. Two mutations were detected in one of the granulosa cell tumours: a mis-sense mutation affecting the putative ‘start’ codon (ATG → ACG, M1T); and a silent change in exon 7 (CTT → CTA, leucine). Like BRCA1 and BRCA2, therefore, it appears that LKB1 mutations can cause ovarian tumours when present in the germline, but occur rarely in the soma. The allele loss on 19p13.3 in ovarian cancers almost certainly targets a different gene from LKB1. © 1999 Cancer Research Campaign

Keywords: Peutz-Jeghers, LKB1/STK11, ovary, adenocarcinoma, granulosa cell

Full Text

The Full Text of this article is available as a PDF (86.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amfo K., Neyns B., Teugels E., Lissens W., Bourgain C., De Sutter P., Vandamme B., Vamos E., De Grève J. Frequent deletion of chromosome 19 and a rare rearrangement of 19p13.3 involving the insulin receptor gene in human ovarian cancer. Oncogene. 1995 Jul 20;11(2):351–358. [PubMed] [Google Scholar]
  2. Dong S. M., Kim K. M., Kim S. Y., Shin M. S., Na E. Y., Lee S. H., Park W. S., Yoo N. J., Jang J. J., Yoon C. Y. Frequent somatic mutations in serine/threonine kinase 11/Peutz-Jeghers syndrome gene in left-sided colon cancer. Cancer Res. 1998 Sep 1;58(17):3787–3790. [PubMed] [Google Scholar]
  3. Hemminki A., Markie D., Tomlinson I., Avizienyte E., Roth S., Loukola A., Bignell G., Warren W., Aminoff M., Höglund P. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature. 1998 Jan 8;391(6663):184–187. doi: 10.1038/34432. [DOI] [PubMed] [Google Scholar]
  4. Hemminki A., Tomlinson I., Markie D., Järvinen H., Sistonen P., Björkqvist A. M., Knuutila S., Salovaara R., Bodmer W., Shibata D. Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis. Nat Genet. 1997 Jan;15(1):87–90. doi: 10.1038/ng0197-87. [DOI] [PubMed] [Google Scholar]
  5. Murday V., Slack J. Inherited disorders associated with colorectal cancer. Cancer Surv. 1989;8(1):139–157. [PubMed] [Google Scholar]
  6. Osborne R. J., Leech V. Polymerase chain reaction allelotyping of human ovarian cancer. Br J Cancer. 1994 Mar;69(3):429–438. doi: 10.1038/bjc.1994.79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Pejovic T. Genetic changes in ovarian cancer. Ann Med. 1995 Feb;27(1):73–78. doi: 10.3109/07853899509031940. [DOI] [PubMed] [Google Scholar]
  8. Ravnik-Glavac M., Glavac D., Dean M. Sensitivity of single-strand conformation polymorphism and heteroduplex method for mutation detection in the cystic fibrosis gene. Hum Mol Genet. 1994 May;3(5):801–807. doi: 10.1093/hmg/3.5.801. [DOI] [PubMed] [Google Scholar]
  9. Sato T., Saito H., Morita R., Koi S., Lee J. H., Nakamura Y. Allelotype of human ovarian cancer. Cancer Res. 1991 Oct 1;51(19):5118–5122. [PubMed] [Google Scholar]
  10. Sheffield V. C., Beck J. S., Kwitek A. E., Sandstrom D. W., Stone E. M. The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions. Genomics. 1993 May;16(2):325–332. doi: 10.1006/geno.1993.1193. [DOI] [PubMed] [Google Scholar]
  11. Tomlinson I. P., Houlston R. S. Peutz-Jeghers syndrome. J Med Genet. 1997 Dec;34(12):1007–1011. doi: 10.1136/jmg.34.12.1007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Vidal-Puig A., Moller D. E. Comparative sensitivity of alternative single-strand conformation polymorphism (SSCP) methods. Biotechniques. 1994 Sep;17(3):490-2, 494, 496. [PubMed] [Google Scholar]
  13. Wang Z. J., Taylor F., Churchman M., Norbury G., Tomlinson I. Genetic pathways of colorectal carcinogenesis rarely involve the PTEN and LKB1 genes outside the inherited hamartoma syndromes. Am J Pathol. 1998 Aug;153(2):363–366. doi: 10.1016/S0002-9440(10)65579-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ylikorkala A., Avizienyte E., Tomlinson I. P., Tiainen M., Roth S., Loukola A., Hemminki A., Johansson M., Sistonen P., Markie D. Mutations and impaired function of LKB1 in familial and non-familial Peutz-Jeghers syndrome and a sporadic testicular cancer. Hum Mol Genet. 1999 Jan;8(1):45–51. doi: 10.1093/hmg/8.1.45. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES